| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0304-3959(95)00024-M |
| P698 | PubMed publication ID | 8577480 |
| P50 | author | Stephen B. McMahon | Q29653464 |
| P2093 | author name string | M Koltzenburg | |
| Andreev NYu | |||
| N Dimitrieva | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 109-115 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Pain | Q2317902 |
| P1476 | title | Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones | |
| P478 | volume | 63 |
| Q33819799 | A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. |
| Q41049950 | A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. |
| Q41719698 | A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice |
| Q48527747 | A unilateral sympathetic blockade does not affect stress-related pain and muscle activity in patients with chronic musculoskeletal pain |
| Q35064559 | Antagonism of nerve growth factor-TrkA signaling and the relief of pain |
| Q26746194 | Anti-nerve growth factor in pain management: current evidence |
| Q40205992 | Artemin has potent neurotrophic actions on injured C-fibres. |
| Q34636446 | Arthritis and pain. Future targets to control osteoarthritis pain |
| Q48420373 | Attenuation of mechanical hyperalgesia following spinal cord injury by administration of antibodies to nerve growth factor in the rat. |
| Q41827937 | Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis |
| Q37947691 | Biologics: the next-generation therapeutics for analgesia? |
| Q28571753 | Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord |
| Q74269192 | Carrageenan-induced thermal hyperalgesia in the mouse: role of nerve growth factor and the mitogen-activated protein kinase pathway |
| Q33656168 | Causalgia and reflex sympathetic dystrophy: does the sympathetic nervous system contribute to the generation of pain? |
| Q82028816 | Chapter 25 The autonomic nervous system and pain |
| Q35047191 | Chronic NGF treatment of rat nociceptive DRG neurons in culture facilitates desensitization and deactivation of GABAA receptor-mediated currents |
| Q42131248 | Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotonin |
| Q58766601 | Constitutive activity of transient receptor potential vanilloid type 1 triggers spontaneous firing in nerve growth factor-treated dorsal root ganglion neurons of rats |
| Q39298750 | Cough reflex hypersensitivity: A role for neurotrophins |
| Q35026207 | Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha |
| Q44451964 | Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. |
| Q73374935 | Differential effect of brain-derived neurotrophic factor on high-threshold mechanosensitivity in a rat neuropathic pain model |
| Q60705113 | Diversity of neurotrophin action in the postnatal spinal cord |
| Q36931658 | Emerging drugs for osteoarthritis |
| Q40242652 | Glial cell line-derived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. |
| Q37079325 | Inhibition of endogenous NGF degradation induces mechanical allodynia and thermal hyperalgesia in rats |
| Q59674065 | Intracerebroventricular infusion of nerve growth factor induces pain-like response in rats |
| Q61071120 | Intrathecal NGF Administration Reduces Reactive Astrocytosis and Changes Neurotrophin Receptors Expression Pattern in a Rat Model of Neuropathic Pain |
| Q43175586 | Involvement of interleukin-1 beta, nerve growth factor and prostaglandin E2 in endotoxin-induced localized inflammatory hyperalgesia |
| Q50531221 | Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. |
| Q44264141 | Local nociceptor sensitization with NGF: mechanical or heat hyperalgesia á la carte? |
| Q60706853 | Lumbar 5 ventral root transection-induced upregulation of nerve growth factor in sensory neurons and their target tissues: a mechanism in neuropathic pain |
| Q47880303 | Lysophosphatidylserine potentiates nerve growth factor-induced differentiation of PC12 cells |
| Q38508116 | Mechanisms and Mediators That Drive Arthritis Pain |
| Q33610520 | Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain. |
| Q35042934 | Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13 |
| Q48602941 | Neonatally wounded skin induces NGF-independent sensory neurite outgrowth in vitro |
| Q60729824 | Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome |
| Q92400214 | Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety |
| Q48636562 | Nerve growth factor depletion by autoimmunization produces thermal hypoalgesia in adult rats |
| Q77623877 | Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75 |
| Q74499213 | Nerve growth factor induces systemic hyperalgesia after thoracic burn injury in the rat |
| Q73797605 | Nerve growth factor- and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord |
| Q39098815 | Nerve growth factor: a neuroimmune crosstalk mediator for all seasons |
| Q34520137 | Nerve growth factor: a neurokine orchestrating neuroimmune-endocrine functions |
| Q34163210 | Neuronal changes resulting in up-regulation of alpha-1 adrenoceptors after peripheral nerve injury |
| Q34326567 | Neurotrophic factors: important regulators of nociceptive function |
| Q48174754 | Neurotrophin activation of NFAT-dependent transcription contributes to the regulation of pro-nociceptive genes |
| Q48364049 | Neurotrophin receptor expression is induced in a subpopulation of trigeminal neurons that label by retrograde transport of NGF or fluoro-gold following tooth injury |
| Q33679514 | Neurotrophins and hyperalgesia. |
| Q53747564 | Neurotrophins from dorsal root ganglia trigger allodynia after spinal nerve injury in rats. |
| Q33670613 | Neurotrophins, nociceptors, and pain |
| Q44597445 | Neurotrophin‐3 down‐regulates trkA mRNA, NGF high‐affinity binding sites, and associated phenotype in adult DRG neurons |
| Q36831523 | Orofacial pain in cancer: part I--mechanisms |
| Q33728157 | Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. |
| Q59126105 | Oxycodone regulates incision-induced activation of neurotrophic factors and receptors in an acute post-surgery pain rat model |
| Q39176086 | PG110, A Humanized Anti-NGF Antibody, Reverses Established Pain Hypersensitivity in Persistent Inflammatory Pain, but not Peripheral Neuropathic Pain, Rat Models |
| Q21203937 | Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats |
| Q47243078 | Peripheral Synthesis of an Atypical Protein Kinase C Mediates the Enhancement of Excitability and the Development of Mechanical Hyperalgesia Produced by Nerve Growth Factor |
| Q41587254 | Peripheral pain mechanisms |
| Q52190288 | Postnatal NGF administration causes adult hyperalgesia and overreactivity to social stimuli but does not reverse capsaicin induced hypoalgesia. |
| Q35025413 | Potentiation of ATP-responses at a recombinant P2x2 receptor by neurotransmitters and related substances |
| Q33973098 | Presence of NGF and its receptor TrkA in degenerative lumbar facet joint specimens. |
| Q38185068 | Pro-neurotrophins, sortilin, and nociception |
| Q44607464 | Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity |
| Q37351925 | Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision |
| Q34329997 | Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons |
| Q43832526 | Small primary sensory neurons innervating epidermis and viscera display differential phenotype in the adult rat. |
| Q52684421 | Swedish Nerve Growth Factor Mutation (NGFR100W) Defines a Role for TrkA and p75NTR in Nociception. |
| Q90732159 | TIMP-1 Attenuates the Development of Inflammatory Pain Through MMP-Dependent and Receptor-Mediated Cell Signaling Mechanisms |
| Q35079184 | Temporal mismatch between pain behaviour, skin Nerve Growth factor and intra-epidermal nerve fibre density in trigeminal neuropathic pain. |
| Q36178912 | The Effect of Repeated Electroacupuncture Analgesia on Neurotrophic and Cytokine Factors in Neuropathic Pain Rats |
| Q48284194 | The induction of pain: an integrative review |
| Q34803161 | The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. |
| Q38185066 | The molecular interplay between endocannabinoid and neurotrophin signals in the nervous system and beyond |
| Q43996597 | The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation |
| Q36179783 | The therapeutic potential of neuropeptide Y in central nervous system disorders with special reference to pain and sympathetically maintained pain |
| Q38176354 | Tissue injury and related mediators of pain exacerbation |
Search more.